Vaccination saves lives: a real-time study of patients with chronic diseases and severe COVID-19 infection

Author:

Mukherjee A1,Kumar G1,Turuk A1,Bhalla A2,Bingi T C3,Bhardwaj P4,Baruah T D5,Mukherjee S6,Talukdar A7,Ray Y8,John M9,Khambholja J R10,Patel A H11,Bhuniya S12,Joshi R13,Menon G R14,Sahu D14,Rao V V14,Bhargava B1,Panda S1,Mishra P,Panchal Y,Sharma L K,Agarwal A,Puri G D,Suri V,Singla K,Mesipogu R,Aedula V S,Mohiuddin M A,Kumar D,Saurabh S,Misra S,Kannauje P K,Kumar A,Shukla A,Pal A,Chakraborty S,Dutta M,Mondal T,Chakravorty S,Bhattacharjee B,Paul S R,Majumder D,Chatterjee S,Abraham A,Varghese D,Thomas M,Shah N,Patel M,Madan S,Desai A,Kala Yadhav M L,Madhumathi R,Chetna G S,Ojha U K,Jha R R,Kumar A,Pathak A,Sharma A,Purohit M,Sarangi L,Rath M,Shah A D,Kumar L,Patel P,Dulhani N,Dube S,Shrivastava J,Mittal A,Patnaik L,Sahoo J P,Sharma S,Katyal V K,Katyal A,Yadav N,Upadhyay R,Srivastava S,Srivastava A,Suthar N N,Shah N M,Rajvansh K,Purohit H,Mohapatra P R,Panigrahi M K,Saigal S,Khurana A,Panchal M,Anderpa M,Patel D,Salgar V,Algur S,Choudhury R,Rao M,Nithya D,Gupta B K,Kumar B,Gupta J,Bhandari S,Agrawal A,Shameem M,Fatima N,Pala S,Nongpiur V,Chatterji S,Mukherjee S,Shivnitwar S K,Tripathy S,Lokhande P,Dandu H,Gupta A,Kumar V,Sharma N,Vohra R,Paliwal A,Pavan Kumar M,Bikshapathi Rao A,Kikon N,Kikon R,Manohar K,Sathyanarayana Raju Y,Madharia A,Chakravarty J,Chaubey M,Bandaru R K,Ali Mirza M,Kataria S,Sharma P,Ghosh S,Hazra A,

Affiliation:

1. From the Indian Council of Medical Research , New Delhi, India

2. Postgraduate Institute of Medical Education & Research , Chandigarh, India

3. Gandhi Medical College , Telangana, India

4. All Indian Institute of Medical Sciences , Jodhpur, Rajasthan, India

5. All Indian Institute of Medical Sciences , Raipur, Chhattisgarh, India

6. College of Medicine, Sagore Dutta Hospital , Kolkata, West Bengal, India

7. Medical College , Kolkata, West Bengal, India

8. Infectious Disease and Beliaghata General Hospital , Kolkata, West Bengal, India

9. Christian Medical College , Ludhiana, Punjab, India

10. Smt. NHL, Municipal Medical College , Ahmedabad, Gujarat, India

11. CIMS Hospital , Ahmedabad, Gujarat, India

12. All India Institute of Medical Sciences , Bhubaneswar, Odisha, India

13. All India Institute of Medical Sciences , Bhopal, Madhya Pradesh, India

14. National Institute of Medical Statistics, Indian Council of Medical Research , Delhi, India

Abstract

AbstractObjectivesThis study aims to describe the demographic and clinical profile and ascertain the determinants of outcome among hospitalized coronavirus disease 2019 (COVID-19) adult patients enrolled in the National Clinical Registry for COVID-19 (NCRC).MethodsNCRC is an on-going data collection platform operational in 42 hospitals across India. Data of hospitalized COVID-19 patients enrolled in NCRC between 1st September 2020 to 26th October 2021 were examined.ResultsAnalysis of 29 509 hospitalized, adult COVID-19 patients [mean (SD) age: 51.1 (16.2) year; male: 18 752 (63.6%)] showed that 15 678 (53.1%) had at least one comorbidity. Among 25 715 (87.1%) symptomatic patients, fever was the commonest symptom (72.3%) followed by shortness of breath (48.9%) and dry cough (45.5%). In-hospital mortality was 14.5% (n = 3957). Adjusted odds of dying were significantly higher in age group ≥60 years, males, with diabetes, chronic kidney diseases, chronic liver disease, malignancy and tuberculosis, presenting with dyspnoea and neurological symptoms. WHO ordinal scale 4 or above at admission carried the highest odds of dying [5.6 (95% CI: 4.6–7.0)]. Patients receiving one [OR: 0.5 (95% CI: 0.4–0.7)] or two doses of anti-SARS CoV-2 vaccine [OR: 0.4 (95% CI: 0.3–0.7)] were protected from in-hospital mortality.ConclusionsWHO ordinal scale at admission is the most important independent predictor for in-hospital death in COVID-19 patients. Anti-SARS-CoV2 vaccination provides significant protection against mortality.

Funder

Indian Council of Medical Research

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3